Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARNA

Arena Pharmaceuticals (ARNA) Stock Price, News & Analysis

Arena Pharmaceuticals logo

About Arena Pharmaceuticals Stock (NASDAQ:ARNA)

Advanced Chart

Key Stats

Today's Range
$99.99
$99.99
50-Day Range
$93.13
$99.99
52-Week Range
$45.50
$100.00
Volume
107 shs
Average Volume
1.56 million shs
Market Capitalization
$6.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arena Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARNA Stock News Headlines

Arwana Citramulia Tbk (ARNA)
Banks aren’t ready for this altcoin—are you?
In crypto, timing is everything. By the time the masses catch wind of this, the biggest gains could be ancient history. Are you ready to potentially change your financial future forever?
RNA startup launches with $300M, Merck partnership
Arna L. Davidson
See More Headlines

ARNA Stock Analysis - Frequently Asked Questions

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced its quarterly earnings data on Thursday, November, 4th. The biopharmaceutical company reported ($3.21) EPS for the quarter, missing analysts' consensus estimates of ($2.53) by $0.68.

Arena Pharmaceuticals shares reverse split on Monday, June 19th 2017.The 1-10 reverse split was announced on Wednesday, June 14th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 16th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arena Pharmaceuticals investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Cytokinetics (CYTK), Micron Technology (MU), Bristol Myers Squibb (BMY) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/04/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ARNA
Employees
448
Year Founded
1977

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$616.43 million
Pretax Margin
-1,141,542.63%

Debt

Sales & Book Value

Annual Sales
$50 thousand
Price / Sales
123,305.67
Price / Cash Flow
N/A
Book Value
$10.94 per share
Price / Book
9.14

Miscellaneous

Free Float
60,173,000
Market Cap
$6.17 billion
Optionable
Optionable
Beta
0.55

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ARNA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners